Business Services Industry
SanDisk Applauds Amazon.com and EMI Music on Launch of MP3 Music Download Store
Business Wire, May 16, 2007
MILPITAS, Calif. -- SanDisk([R]) Corporation (NASDAQ:SNDK), the second largest seller of MP3 players in the United States, today released the following statement by Daniel Schreiber, senior vice president and general manager of the audio and video business unit at SanDisk:
"We at SanDisk are excited by Amazon.com's announcement today of a DRM-free music download store, supported by EMI Music, that will offer tracks in the MP3 format. This is the first time a major record label and a major retailer have come together to offer consumers the freedom to buy music compatible with all MP3 players. As consistent advocates of consumer choice, we believe this is an important step forward."
Related Results
Schreiber and other SanDisk executives are available today to comment further.
SanDisk offers a wide array of MP3 players in its Sansa([R]) line, including the Sansa Connect([TM]) with WiFi, the affordable Sansa Express([TM]), the Sansa Shaker([TM]) for young people, and the mainstream Sansa c200, m200 and e200 series.
SanDisk is the original inventor of flash storage cards and is the world's largest supplier of flash data storage card products, using its patented, high-density flash memory and controller technology. SanDisk is headquartered in Milpitas, CA and has operations worldwide, with more than half its sales outside the U.S.
SanDisk's product and executive images can be downloaded from http://www.sandisk.com/corporate/media.asp. The Sansa Shaker player is intended for children 8 years old and up.
SanDisk's web site/home page address: http://www.sandisk.com
SanDisk, the SanDisk logo and Sansa are trademarks of SanDisk Corporation, registered in the United States and other countries. Sansa Connect, Sansa Express and Sansa Shaker are trademarks of SanDisk Corporation. Other brand names mentioned herein are for identification purposes only and may be the trademarks of their respective holder (s).
This media advisory contains certain forward-looking statements, including expectations for new product introductions, applications, markets, and customers that are based on our current expectations and involve numerous risks and uncertainties that may cause these forward-looking statements to be inaccurate. Risks that may cause these forward-looking statements to be inaccurate include among others: market demand for our products may grow more slowly than our expectations, there may be a slower adoption rate for these products in new markets that we are targeting, our products may not perform as expected, and the other risks detailed from time-to-time in our Securities and Exchange Commission filings and reports, including, but not limited to, Form 10-K and our quarterly reports on Form 10-Q. We do not intend to update the information contained in this press release.
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


